DFTX
Definium Therapeutics, Inc.
Price Chart
No historical data available
Latest Quote
$40.98
-2.84 (-6.48%)
Current Price
| Previous Close | $43.82 |
| Open | $43.18 |
| Day High | $43.38 |
| Day Low | $40.85 |
| Volume | 1,801,715 |
Stock Information
| Shares Outstanding | 134.37M |
| Total Debt | $36.47M |
| Cash Equivalents | $1.08B |
| Net Income | $-353.78M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $5.51B |
| EPS (TTM) | $-3.21 |
| Exchange | NMS |
Recent Price History
No history data available. Data will be fetched automatically.
About Definium Therapeutics, Inc.
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.
đ° Latest News
No news articles available at the moment. Check back later for updates on DFTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $5,482,000 | $2,283,000 | $920,000 | - |
| Total Expenses | $166,309,000 | $103,916,000 | $93,866,000 | $66,331,000 |
| Other Income Expense | $-22,962,000 | $-14,038,000 | $-6,530,000 | $8,040,000 |
| Net Non Operating Interest Income Expense | $5,478,000 | $9,275,000 | $4,664,000 | $1,495,000 |
| Interest Expense Non Operating | $5,482,000 | $2,283,000 | $920,000 | - |
| Operating Expense | $166,309,000 | $103,916,000 | $93,866,000 | $66,331,000 |
| General And Administrative Expense | $48,644,000 | $38,619,000 | $41,742,000 | $30,162,000 |
| Other Non Operating Income Expenses | - | - | $-51,000 | $2,000 |
| Total Other Finance Cost | - | - | $-4,664,000 | $-1,495,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Net Interest Income | $5,478,000 | $9,275,000 | $4,664,000 | $1,495,000 |
| Interest Income | $10,960,000 | $11,558,000 | $5,584,000 | - |
| Normalized Income | $-160,831,000 | $-94,641,000 | $-89,253,000 | $-64,834,000 |
| Net Income From Continuing And Discontinued Operation | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Total Operating Income As Reported | $-166,309,000 | $-103,916,000 | $-93,866,000 | $-66,331,000 |
| Net Income Common Stockholders | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Net Income | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Net Income Including Noncontrolling Interests | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Net Income Continuous Operations | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Pretax Income | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Special Income Charges | $0 | $2,541,000 | $0 | - |
| Interest Income Non Operating | $10,960,000 | $11,558,000 | $5,584,000 | - |
| Operating Income | $-166,309,000 | $-103,916,000 | $-93,866,000 | $-66,331,000 |
| Per Share | ||||
| Diluted EPS | $-2.06 | $-1.54 | $-2.44 | $-1.84 |
| Basic EPS | $-2.06 | $-1.54 | $-2.44 | $-1.84 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-155,349,000 | $-91,831,000 | $-85,171,000 | $-71,189,000 |
| Total Unusual Items | $-22,962,000 | $-14,038,000 | $-6,479,000 | $8,038,000 |
| Total Unusual Items Excluding Goodwill | $-22,962,000 | $-14,038,000 | $-6,479,000 | $8,038,000 |
| Reconciled Depreciation | $0 | $527,000 | $3,162,000 | $3,180,000 |
| EBITDA (Bullshit earnings) | $-178,311,000 | $-105,869,000 | $-91,650,000 | $-63,151,000 |
| EBIT | $-178,311,000 | $-106,396,000 | $-94,812,000 | $-66,331,000 |
| Diluted Average Shares | $89,327,608 | $70,461,067 | $39,157,420 | $30,857,463 |
| Basic Average Shares | $89,327,608 | $70,461,067 | $39,157,420 | $30,857,463 |
| Diluted NI Availto Com Stockholders | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Gain On Sale Of Security | $-22,962,000 | $-16,579,000 | $-6,479,000 | $8,038,000 |
| Research And Development | $117,665,000 | $65,297,000 | $52,124,000 | $36,169,000 |
| Selling General And Administration | $48,644,000 | $38,619,000 | $41,742,000 | $30,162,000 |
| Other Gand A | $48,644,000 | $38,619,000 | $41,742,000 | $30,162,000 |
| Other Special Charges | - | $-2,541,000 | - | - |
| Tax Provision | - | - | - | $0 |
Fetched: 2026-08-28
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $312,409,000 | $221,530,000 | $57,689,000 | $127,310,000 |
| Total Assets | $440,100,000 | $302,151,000 | $124,541,000 | $169,993,000 |
| Total Non Current Assets | $20,780,000 | $20,531,000 | $20,669,000 | $23,938,000 |
| Other Non Current Assets | $862,000 | $613,000 | $224,000 | $331,000 |
| Goodwill And Other Intangible Assets | $19,918,000 | $19,918,000 | $20,445,000 | $23,607,000 |
| Current Assets | $419,320,000 | $281,620,000 | $103,872,000 | $146,055,000 |
| Other Current Assets | $7,727,000 | $7,879,000 | $4,168,000 | $3,913,000 |
| Cash Cash Equivalents And Short Term Investments | $411,593,000 | $273,741,000 | $99,704,000 | $142,142,000 |
| Cash And Cash Equivalents | $257,837,000 | $273,741,000 | $99,704,000 | $142,142,000 |
| Other Intangible Assets | - | - | $527,000 | $3,689,000 |
| Prepaid Assets | - | - | - | $3,913,000 |
| Cash Financial | - | - | - | - |
| Debt | ||||
| Total Debt | $40,579,000 | $21,854,000 | $14,129,000 | $72,000 |
| Long Term Debt And Capital Lease Obligation | $40,579,000 | $21,854,000 | $14,129,000 | - |
| Long Term Debt | $40,579,000 | $21,854,000 | $14,129,000 | - |
| Current Debt And Capital Lease Obligation | - | - | - | $72,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $107,773,000 | $60,703,000 | $46,407,000 | $19,076,000 |
| Total Non Current Liabilities Net Minority Interest | $41,075,000 | $21,854,000 | $14,161,000 | $1,184,000 |
| Other Non Current Liabilities | $496,000 | - | $32,000 | $1,184,000 |
| Current Liabilities | $66,698,000 | $38,849,000 | $32,246,000 | $17,892,000 |
| Other Current Liabilities | $40,905,000 | $24,010,000 | $16,476,000 | $9,904,000 |
| Payables And Accrued Expenses | $16,326,000 | $8,434,000 | $11,244,000 | $4,790,000 |
| Payables | $5,347,000 | $2,010,000 | $6,977,000 | $3,677,000 |
| Accounts Payable | $5,347,000 | $2,010,000 | $4,136,000 | $2,111,000 |
| Other Payable | - | - | $2,841,000 | $1,566,000 |
| Tradeand Other Payables Non Current | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $332,327,000 | $241,448,000 | $78,134,000 | $150,917,000 |
| Total Equity Gross Minority Interest | $332,327,000 | $241,448,000 | $78,134,000 | $150,917,000 |
| Stockholders Equity | $332,327,000 | $241,448,000 | $78,134,000 | $150,917,000 |
| Gains Losses Not Affecting Retained Earnings | $1,085,000 | $819,000 | $343,000 | $627,000 |
| Other Equity Adjustments | $1,085,000 | $819,000 | $343,000 | $627,000 |
| Retained Earnings | $-582,672,000 | $-398,879,000 | $-290,200,000 | $-194,468,000 |
| Other | ||||
| Ordinary Shares Number | $98,776,265 | $75,100,763 | $41,101,303 | $37,979,136 |
| Share Issued | $98,776,265 | $75,100,763 | $41,101,303 | $37,979,136 |
| Tangible Book Value | $312,409,000 | $221,530,000 | $57,689,000 | $127,310,000 |
| Invested Capital | $372,906,000 | $263,302,000 | $92,263,000 | $150,917,000 |
| Working Capital | $352,622,000 | $242,771,000 | $71,626,000 | $128,163,000 |
| Total Capitalization | $372,906,000 | $263,302,000 | $92,263,000 | $150,917,000 |
| Additional Paid In Capital | $913,914,000 | $639,508,000 | $367,991,000 | $344,758,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $9,467,000 | $6,405,000 | $4,526,000 | $3,198,000 |
| Current Accrued Expenses | $10,979,000 | $6,424,000 | $4,267,000 | $1,113,000 |
| Goodwill | $19,918,000 | $19,918,000 | $19,918,000 | $19,918,000 |
| Other Short Term Investments | $153,756,000 | $0 | - | - |
| Capital Lease Obligations | - | - | - | $72,000 |
| Current Capital Lease Obligation | - | - | - | $72,000 |
Fetched: 2026-08-28
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-131,560,000 | $-79,129,000 | $-64,365,000 | $-50,139,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-131,560,000 | $-79,129,000 | $-64,365,000 | $-50,139,000 |
| Cash Flow From Continuing Operating Activities | $-131,560,000 | $-79,129,000 | $-64,365,000 | $-50,139,000 |
| Operating Gains Losses | $22,831,000 | $16,447,000 | $6,273,000 | $-6,491,000 |
| Investing Activities | ||||
| Investing Cash Flow | $-151,606,000 | $0 | - | $0 |
| Cash Flow From Continuing Investing Activities | $-151,606,000 | $0 | - | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $258,858,000 | $250,983,000 | $0 | $42,297,000 |
| Financing Cash Flow | $267,269,000 | $253,196,000 | $21,848,000 | $59,051,000 |
| Cash Flow From Continuing Financing Activities | $267,269,000 | $253,196,000 | $21,848,000 | $59,051,000 |
| Net Other Financing Charges | $-12,626,000 | $-8,503,000 | $114,000 | $-1,907,000 |
| Net Common Stock Issuance | $258,858,000 | $250,983,000 | $0 | $42,297,000 |
| Common Stock Issuance | $258,858,000 | $250,983,000 | $0 | $42,297,000 |
| Other | ||||
| Repayment Of Debt | $-22,000,000 | $0 | $-844,000 | $0 |
| Issuance Of Debt | $42,000,000 | $10,000,000 | $22,529,000 | $0 |
| Interest Paid Supplemental Data | $5,338,000 | $2,224,000 | $534,000 | $0 |
| End Cash Position | $257,837,000 | $273,741,000 | $99,704,000 | $142,142,000 |
| Beginning Cash Position | $273,741,000 | $99,704,000 | $142,142,000 | $133,539,000 |
| Effect Of Exchange Rate Changes | $-7,000 | $-30,000 | $79,000 | $-309,000 |
| Changes In Cash | $-15,897,000 | $174,067,000 | $-42,517,000 | $8,912,000 |
| Proceeds From Stock Option Exercised | $1,037,000 | $716,000 | $49,000 | $18,661,000 |
| Net Issuance Payments Of Debt | $20,000,000 | $10,000,000 | $21,685,000 | $0 |
| Net Long Term Debt Issuance | $20,000,000 | $10,000,000 | $21,685,000 | $0 |
| Long Term Debt Payments | $-22,000,000 | $0 | $-844,000 | $0 |
| Long Term Debt Issuance | $42,000,000 | $10,000,000 | $22,529,000 | $0 |
| Net Investment Purchase And Sale | $-151,606,000 | $0 | - | - |
| Sale Of Investment | $116,750,000 | $0 | - | - |
| Purchase Of Investment | $-268,356,000 | $0 | - | - |
| Change In Working Capital | $9,437,000 | $-3,344,000 | $6,281,000 | $-3,782,000 |
| Change In Other Current Liabilities | $-40,000 | $-32,000 | $-1,152,000 | $-870,000 |
| Change In Other Current Assets | $30,000 | $48,000 | $51,000 | $-180,000 |
| Change In Payables And Accrued Expense | $9,295,000 | $977,000 | $7,343,000 | $-2,472,000 |
| Change In Accrued Expense | $5,958,000 | $3,103,000 | $5,318,000 | $-416,000 |
| Change In Payable | $3,337,000 | $-2,126,000 | $2,025,000 | $-2,056,000 |
| Change In Account Payable | $3,337,000 | $-2,126,000 | $2,025,000 | $-2,056,000 |
| Change In Prepaid Assets | $152,000 | $-4,337,000 | $39,000 | $-260,000 |
| Other Non Cash Items | $1,690,000 | $-993,000 | $468,000 | $43,000 |
| Stock Based Compensation | $20,096,000 | $16,913,000 | $15,183,000 | $13,707,000 |
| Amortization Of Securities | $-1,821,000 | $0 | - | - |
| Depreciation Amortization Depletion | $0 | $527,000 | $3,162,000 | $3,180,000 |
| Depreciation And Amortization | $0 | $527,000 | $3,162,000 | $3,180,000 |
| Amortization Cash Flow | $0 | $527,000 | $3,162,000 | $3,180,000 |
| Amortization Of Intangibles | $0 | $527,000 | $3,162,000 | $3,180,000 |
| Gain Loss On Investment Securities | $22,831,000 | $15,941,000 | $6,636,000 | $-6,343,000 |
| Net Foreign Currency Exchange Gain Loss | $0 | $506,000 | $-363,000 | $-148,000 |
| Net Income From Continuing Operations | $-183,793,000 | $-108,679,000 | $-95,732,000 | $-56,796,000 |
| Net Business Purchase And Sale | - | - | - | $0 |
| Purchase Of Business | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | $-180,000 |
Fetched: 2026-08-28